efgartigimod
argenx
['argenx']
this past weekend, we demonstrated our continued commitment to the #itp community at #eha2023, where dr. carpenedo presented interim results of our advance+ study. #togetherwediscover #plateletdisorder #immunethrombocytopenia 
We’re a global immunology company using co-creation to develop potential therapies for people with severe autoimmune diseases and cancer.